TrialThoracic cancer2022

Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancer.

Xiang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.